1. Aali B & Naderi T 2004. Evaluation of clinical, ultrasound and laboratory features of PCOS in Kerman in 1381. Iranian journal of endocrinology and metabolism. 6: 153-161.
2. Abu-Wasel B, Walsh C, Keough V & Molinari M 2013. Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases. World journal of gastroenterology. 19 (35): 5775.
3. Asghari G, et al. 2012. Reliability, comparative validity and stability of dietary patterns derived from an FFQ in the Tehran Lipid and Glucose Study. British journal of nutrition. 108 (6): 1109-1117.
4. Azziz R, Marin C, Hoq L, Badamgarav E & Song P 2005. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. Journal of clinical endocrinology & metabolism. 90 (8): 4650-4658.
5. Berek J 2012. Berek and Novak s gynecology, 15th ed.
6. Blüher M 2013. Adipose tissue dysfunction contributes to obesity related metabolic diseases. Best practice & research clinical endocrinology & metabolism. 27 (2): 163-177.
7. Brynes AE, et al. 2003. A randomised four-intervention crossover study investigating the effect of carbohydrates on daytime profiles of insulin, glucose, non-esterified fatty acids and triacylglycerols in middle-aged men. British journal of nutrition. 89 (2): 207-218.
8. Conway G, et al. 2014. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. European journal of endocrinology. 171 (4): P1-P29.
9. Douglas CC, et al. 2006. Difference in dietary intake between women with polycystic ovary syndrome and healthy controls. Fertility and sterility. 86 (2): 411-417.
10. Ebbeling CB, et al. 2005. Effects of an ad libitum low-glycemic load diet on cardiovascular disease risk factors in obese young adults. American journal of clinical nutrition. 81 (5): 976-982.
11. Ehsani B, Moslehi N & Mirmiran P 2015. Effects of Hypo-caloric Ddiet and Dietary Composition on Reproductive and Metabolic Disorders in Women with Polycystic Ovary Syndrome: A Review of Studies. Iranian journal of nutrition sciences & food technology. 10 (2): 103-114.
12. ESHRE T & ASRM-Sponsored PCOS Consensus Workshop Group 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and sterility. 81 (1): 19-25.
13. Gabrielli L & Aquino E 2012. Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare. Gabrielli and Aquino. Reproductive Biology and Endocrinology 10 (1): 96.
14. Goodarzi M, Dumesic D, Chazenbalk G & Azziz R 2011. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nature reviews endocrinology. 7 (4): 219-231.
15. Graff SK, Mário FM, Alves BC & Spritzer PM 2013. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes. Fertility and sterility. 100 (4): 1081-1088.
16. Hashemi S, Tehrani F, Noroozzadeh M & Azizi F 2014. Normal cut-off values for hyperandrogenaemia in Iranian women of reproductive age. European journal of obstetrics & gynecology and reproductive biology. 172: 51-55.
17. Hernández-Valencia M, Hernández-Rosas M & Zárate A 2010. Care of insulin resistance in polycystic ovary syndrome. Ginecologia y obstetricia de Mexico. 78 (11): 612-616.
18. Homayounfar R, et al. 2013. Diet-induced metabolic syndrome model in rats. Journal of Fasa University of medical sciences. 2 (4): 288-296.
19. Hosseini-Esfahani F, et al. 2015. Interaction of APOC3 polymorphism and dietary fats on the risk of metabolic syndrome. Iranian journal of endocrinology and metabolism. 16 (5): 345-355.
20. Kar S 2013. Anthropometric, clinical, and metabolic comparisons of the four Rotterdam PCOS phenotypes: A prospective study of PCOS women. Journal of human reproductive sciences. 6 (3): 194-200.
21. Kasim-Karakas SE, et al. 2004. Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism. 89 (2): 615-620.
22. Kauffman RP, Baker VM, DiMarino P, Gimpel T & Castracane VD 2002. Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations. American journal of obstetrics and gynecology. 187 (5): 1362-1369.
23. Kim HM, Park J, Ryu SY & Kim J 2007. The effect of menopause on the metabolic syndrome among Korean women: the Korean National Health and Nutrition Examination Survey, 2001. Diabetes care. 30 (3): 701-706.
24. Legro RS, et al. 2013. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. Journal of clinical endocrinology & metabolism. 98 (12): 4565-4592.
25. Matthews D, et al. 1985. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28 (7): 412-419.
26. McLaughlin T, et al. 2016. Adipose cell size and regional fat deposition as predictors of metabolic response to overfeeding in insulin-resistant and insulin-sensitive humans. Diabetes. 65 (5): 1245-1254.
27. Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M & Azizi F 2010. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public health nutrition. 13 (5): 654-662.
28. Moran L, et al. 2013. The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome. Human reproduction. 28 (8): 2276-2283.
30. Panagiotakos DB, et al. 2005. The relationship between dietary habits, blood glucose and insulin levels among people without cardiovascular disease and type 2 diabetes; the ATTICA study. Review of diabetic studies. 2 (4): 208.
31. Pehlivanov B & Orbetzova M 2007. Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population. Gynecological endocrinology. 23 (10): 604-609.
32. Ramezani F, Rashidi H & Azizi F 2011. The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study. Reproductive biology and endocrinology. 9: 144.
33. Saidpour A, et al. 2011. Effects of high-fat diets based on butter or soybean, olive or fish oil on insulin resistance and plasma desacyl-ghrelin in rats. Iranian journal of nutrition sciences & food technology. 6 (3): 39-48.
34. Schorge J, et al. 2008. Williams gynecology. McGraw-Hill Medical New York.
35. Sjaarda LA, et al. 2015. Dietary carbohydrate intake does not impact insulin resistance or androgens in healthy, eumenorrheic women. Journal of clinical endocrinology & metabolism. 100 (8): 2979-2986.
36. Stender S & Dyerberg J 2004. Influence of trans fatty acids on health. Annals of nutrition and metabolism. 48 (2): 61-66.
37. Tehrani F, Rashidi H, Khomami M, Tohidi M & Azizi F 2014. The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran. Reproductive biology and endocrinology. 12 (1): 1-6.
38. Thomson R, et al. 2009. The effect of weight loss on anti-Müllerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment. Human reproduction. 24 (8): 1976-1981.
39. Tierney AC & Roche HM 2007. The potential role of olive oil‐derived MUFA in insulin sensitivity. Molecular nutrition & food research. 51 (10): 1235-1248.
40. Wallace T, Levy J & Matthews D 2004. Use and abuse of HOMA modeling. Diabetes care. 27 (6): 1487-1495.
41. Williams C 1995. Macronutrients and performance. Journal of sports sciences. 13 (51): s1-s10.
42. XIA HX & ZHANG W 2012. Study of Association between Polycystic Ovary Syndrome and Dietary Intake. Journal of reproduction & contraception. 23 (1): 29-40.
43. Zangeneh F, Naghizadeh M, Bagheri M & Jafarabadi M 2017. Are CRH & NGF as psychoneuroimmune regulators in women with polycystic ovary syndrome? Gynecological endocrinology. 33 (3): 227-233.
44. Zhang J, et al. 2015. High intake of energy and fat in Southwest Chinese women with PCOS: a population-based case-control study. PloS one. 10 (5): e0127094.
45. Zivkovic AM, German JB & Sanyal AJ 2007. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. American journal of clinical nutrition. 86 (2): 285-300.